AstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approving the ...

Committee for Medicinal Products for Human Use (CHMP) has recommended approving AstraZeneca’s Fasenra (benralizumab) to treat ...

The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids.

EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

The best ad blockers are unfortunately very necessary to survive on the modern internet. It doesn't matter which sites you browse, there's the risk of being harassed by pop-ups, tracker cookies ...

An additional study is underway to assess depemokimab in severe asthma patients who are switched from GSK’s own Nucala (mepolizumab) or AstraZeneca’s Fasenra (benralizumab).

Opens in a new tab or window A safety update for abrocitinib has shown the drug to be safe out to nearly 4 years for the treatment of moderate-to-severe atopic dermatitis (AD). The risk of adverse ...

ASUNCIÓN, Paraguay (AP) — A powerful drought in the Amazon rainforest has led to the lowest water levels on the Paraguay River in more than a century, disrupting commerce on the major waterway ...

ORLANDO, FLA. (AP) — Kick-off for Saturday's Sam Houston-at-UCF college football game has been pushed back at least a half hour because of severe weather.